Pamela Pinzani
Overview
Explore the profile of Pamela Pinzani including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
80
Citations
1527
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Gelmini S, Calabri A, Mancini I, Comin C, Pasini V, Banini M, et al.
Int J Mol Sci
. 2025 Jan;
26(2.
PMID: 39859325
The expression level of Programmed Death-Ligand 1 (PD-L1) determined by the immunohistochemical method is currently approved to test the potential efficacy of immune-checkpoint inhibitors and to candidate patients with Non-Small...
2.
Malentacchi F, Mancini I, Villari D, Forster M, Marzocco A, Galli I, et al.
Curr Issues Mol Biol
. 2024 Dec;
46(12):13881-13892.
PMID: 39727957
Circulating tumor cells and cell-free nucleic acids are novel diagnostic, prognostic and predictive tools for non-invasive and cost-effective cancer detection in liquid biopsy. Carbonic anhydrase IX (CAIX) has been proposed...
3.
Lavacchi D, Gelmini S, Calabri A, Rossi G, Simi L, Caliman E, et al.
Heliyon
. 2023 Nov;
9(11):e21853.
PMID: 38027900
The detection of RAS mutations and co-mutations in liquid biopsy offers a novel paradigm for the dynamic management of metastatic colorectal cancer (mCRC) patients. Expanding the results of the prospective...
4.
Devonshire A, Jones G, Gonzalez A, Kofanova O, Trouet J, Pinzani P, et al.
N Biotechnol
. 2023 Sep;
78:13-21.
PMID: 37730172
Analysis of circulating cell-free DNA (ccfDNA) isolated from liquid biopsies is rapidly being implemented into clinical practice. However, diagnostic accuracy is significantly impacted by sample quality and standardised approaches for...
5.
Gaeta R, Righi A, Gambarotti M, Aretini P, Lessi F, Mazzanti C, et al.
Histopathology
. 2022 Jul;
81(3):389-401.
PMID: 35791778
Objective: Chondroblastoma-like osteosarcoma (CBLOS) is a rare and poorly understood variant of OS. We examined the clinicopathological, immunohistochemical and molecular features of six CBLOSs to highlight the differences with conventional...
6.
Francolini G, Loi M, Ciccone L, Detti B, Di Cataldo V, Pinzani P, et al.
Med Oncol
. 2022 Jun;
39(8):119.
PMID: 35687207
Circulating tumor cells detection and ARV7 expression are associated with worse clinical outcomes in metastatic Castration-Resistant Prostate Cancer (mCRPC) undergoing Androgen Receptor Targeted Agents. ARFL, PSMA and PSA may help...
7.
Salvianti F, Gelmini S, Mancini I, Pazzagli M, Pillozzi S, Giommoni E, et al.
Br J Cancer
. 2021 May;
125(1):94-100.
PMID: 33953347
Background: Within the OMITERC prospective study (OMIcs application from solid to liquid biopsy for a personalised ThERapy of Cancer), we explored the prognostic role of liquid biopsy encompassing cell-free DNA...
8.
Pinzani P, DArgenio V, Del Re M, Pellegrini C, Cucchiara F, Salvianti F, et al.
Clin Chem Lab Med
. 2021 Feb;
59(7):1181-1200.
PMID: 33544478
Despite advances in screening and therapeutics cancer continues to be one of the major causes of morbidity and mortality worldwide. The molecular profile of tumor is routinely assessed by surgical...
9.
Baria E, Cicchi R, Malentacchi F, Mancini I, Pinzani P, Pazzagli M, et al.
J Biophotonics
. 2020 Dec;
14(3):e202000365.
PMID: 33305912
Malignant melanoma is an aggressive form of skin cancer, which develops from the genetic mutations of melanocytes - the most frequent involving BRAF and NRAS genes. The choice and the...
10.
Cantini G, Canu L, Armignacco R, Salvianti F, De Filpo G, Ercolino T, et al.
Cancers (Basel)
. 2020 Nov;
12(11).
PMID: 33138000
Adrenocortical carcinoma (ACC), a rare and aggressive neoplasia, presents poor prognosis when metastatic at diagnosis and limited therapies are available. Specific and sensitive markers for early diagnosis and a monitoring...